Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study.
Arrieta O, Martinez-Barrera L, Treviño S, Guzman E, Castillo-Gonzalez P, Rios-Trejo MA, Flores-Estrada D, Téllez E, Gonzalez C, de la Cruz Vargas J, Gonzalez-De la Rosa CH, Hernandez-Pedro N, Morales-Barrera R, De la Garza J.
Arrieta O, et al.
J Thorac Oncol. 2008 Aug;3(8):887-93. doi: 10.1097/JTO.0b013e31818026f6.
J Thorac Oncol. 2008.
PMID: 18670307
Free article.
Clinical Trial.